Quick News Spot

Anuradha Muralidharan Sells 12,320 Shares of Expensify, Inc. (NASDAQ:EXFY) Stock


Anuradha Muralidharan Sells 12,320 Shares of Expensify, Inc. (NASDAQ:EXFY) Stock

Expensify, Inc. (NASDAQ:EXFY - Get Free Report) COO Anuradha Muralidharan sold 12,320 shares of the business's stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $3.85, for a total transaction of $47,432.00. Following the sale, the chief operating officer now directly owns 4,614 shares in the company, valued at $17,763.90. This trade represents a 72.75 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Anuradha Muralidharan also recently made the following trade(s):

Shares of NASDAQ EXFY traded down $0.25 during trading on Wednesday, reaching $3.61. 746,053 shares of the company traded hands, compared to its average volume of 730,777. The stock has a market cap of $278.53 million, a P/E ratio of -20.05 and a beta of 1.90. The firm's fifty day simple moving average is $2.65 and its 200 day simple moving average is $2.18. Expensify, Inc. has a 12-month low of $1.24 and a 12-month high of $4.13.

EXFY has been the topic of a number of recent research reports. JMP Securities lowered Expensify from an "outperform" rating to a "market perform" rating in a research report on Monday, November 25th. Citigroup upped their price objective on shares of Expensify from $4.00 to $5.00 and gave the company a "buy" rating in a report on Monday.

Check Out Our Latest Stock Report on EXFY

Several institutional investors have recently bought and sold shares of EXFY. Walleye Capital LLC lifted its holdings in Expensify by 42.1% in the third quarter. Walleye Capital LLC now owns 603,506 shares of the company's stock valued at $1,183,000 after acquiring an additional 178,911 shares during the period. Marshall Wace LLP purchased a new position in shares of Expensify during the 2nd quarter valued at approximately $53,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Expensify in the 2nd quarter valued at $86,000. Wealthspire Advisors LLC lifted its stake in shares of Expensify by 40.7% in the 2nd quarter. Wealthspire Advisors LLC now owns 66,212 shares of the company's stock valued at $99,000 after purchasing an additional 19,157 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Expensify by 76.9% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 66,095 shares of the company's stock worth $130,000 after buying an additional 28,731 shares in the last quarter. 68.42% of the stock is currently owned by hedge funds and other institutional investors.

Expensify, Inc provides a cloud-based expense management software platform to individuals and corporations, small and midsized businesses, and enterprises in the United States and internationally. The company's platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Expensify, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Expensify wasn't on the list.

While Expensify currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

Previous articleNext article

POPULAR CATEGORY

corporate

3769

tech

4028

entertainment

4625

research

2044

misc

4891

wellness

3642

athletics

4750